LONDON--(BUSINESS WIRE)--Technavio has announced its newest market research report on the global hospital-acquired disease testing market for the period 2018-2022, providing the latest cutting-edge insights on this popular market.
The report will follow up on Technavio’s previous report on global hospital-acquired disease testing market. The research report contains detailed insights, facts, historical data, and statistically supported industry-validated market data. It also includes in-depth analysis of the competitive landscape of significant players and their latest product developments in the market.
The updated research report on the global hospital-acquired disease testing market is an integral part of Technavio’s life science research tools portfolio. Such tools are used in a wide range of fields, such as molecular biology, genetics, biotechnology, cell biology, biochemistry, and biomedicine. Some of the topics in this sector include forensic technologies, artificial organ, hematology analyzers and reagents, cochlear implants, and drug discovery outsourcing.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers
Hospital-acquired disease testing: market opportunities
The hospital-acquired diseases are otherwise called nosocomial diseases that are procured in clinics and other medicinal services offices. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. The most common types of clinic procured diseases are SSIs, UTIs, circulation system contaminations, pneumococcal contaminations, MRSA, and gastrointestinal ailments.
In the previous report, a senior analyst at Technavio stated, “Hospital-acquired diseases appear between 48 hours and four days after a patient is admitted and are generally related with a treatment method used to treat or analyze the patient's underlying sickness or damage. These diseases are preventable through adherence to strict rules and less use of obtrusive hardware that must be trailed by social insurance experts while administering to the patient. The rising prevalence of HAIs is a major driver for the hospital-acquired disease testing market.”
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Topics covered in the previous report include the following:
Key segments
- UTI testing
- SSI testing
- Pneumococcal infections testing
- Bloodstream infections testing
- MRSA testing
Key regions
- Americas
- APAC
- EMEA
Other features
- Market drivers
- Market challenges
- Market trends
- Competitive landscape
- And more
Taking the previous analysis as a base, Technavio’s new report will re-assess the market with an eye for new improvements in the field of hospital-acquired disease testing. The report on the global hospital-acquired disease testing market for the period of 2018-2022 is available to order now and will be delivered within one week of purchase.
| Technavio’s best deals of the month! |
|
Celebrate Earth Day and clean energy with Technavio. Get 30% discount on all Energy reports. Offer valid from 12th March - 18th March. |
| OR |
|
Get 20% off on all Media and Entertainment Services reports. Offer valid only till the 31st of March. |
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
